Juan-Francisco Silvestre

24PUBLICATIONS
77CO-AUTHORS
Traditional Chinese medicine and treatmentsCheminformatics and quantitative structure-activity relationshipsDisease surveillanceAllergyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 08, 2026
Special, Sensitive, and Difficult-to-Treat Areas: Clarifying the Terminology in Atopic Dermatitis.

|Feb 19, 2026
Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC).

David Pesqué, Francisco Javier Ortiz de Frutos, Francisco Navarro-Triviño

|Feb 05, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND.

Andrew Blauvelt, H Chih-Ho Hong, Norito Katoh

|Nov 11, 2025
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis.

Melinda Gooderham, Mahreen Ameen, H Chih-Ho Hong

|Feb 25, 2025
A Review of Hand Eczema Subtypes: Clinical Features, Biomarkers and Treatment Strategies.

David Pesqué, Juan Francisco Silvestre-Salvador, Ana Carolina Figueiredo

|Dec 10, 2024
Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.

Stephan Weidinger, Anthony Bewley, H Chih-Ho Hong

Pageof 4

Frequent Collaborators

12 joint publications

Tatiana Sanz-Sánchez

12 joint publications

Pedro Mercader-García

11 joint publications

Ana María Giménez-Arnau

11 joint publications

Leopoldo Borrego